Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Vaccine‐Based Strategies for Prevention of Staphylococcus Aureus Infection

Schaffer, Adam C., Lee, Jean C.·2009·Staphylococci in Human Disease
DOI 10.1002/9781444308464.ch32
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/9781444308464.ch32

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 132

  1. 10.1056/NEJM199808203390806 · DOI · Paper page
  2. 10.3201/eid1312.070629 · DOI · Paper page
  3. 10.1086/498898 · DOI
  4. 10.1097/INF.0b013e3180616ce4 · DOI
  5. 10.3201/eid0702.010204 · DOI · Paper page
  6. 10.1001/archinte.167.8.854 · DOI
  7. 10.1056/NEJMcp070747 · DOI · Paper page
  8. 10.1016/j.mib.2007.08.003 · DOI · Paper page
  9. 10.3201/eid1303.060960 · DOI
  10. Centers for Disease Control and Prevention, 2004, Vancomycin‐resistant Staphylococcus aureus: New York, 2004, MMWR, 53, 322
  11. Centers for Disease Control and Prevention, 2002, Staphylococcus aureus resistant to vancomycin: United States, 2002, MMWR, 51, 565
  12. 10.1007/978-1-4615-0053-7_18 · doi:10.1007/978-1-4615-0053-7_18
  13. 10.2165/00003495-200666140-00002 · DOI
  14. 10.1016/j.coph.2006.04.005 · DOI
  15. 10.2165/00063030-200822010-00003 · DOI
  16. 10.1128/CDLI.12.3.387-398.2005 · DOI · Paper page
  17. 10.1128/CMR.10.3.505 · DOI · Paper page
  18. 10.1016/S1473-3099(05)70295-4 · DOI · Paper page
  19. 10.1016/S0140-6736(04)16897-9 · DOI · Paper page
  20. 10.1038/nrmicro1289 · DOI · Paper page
  21. 10.1128/JB.00789-07 · DOI
  22. 10.1046/j.1365-2958.2002.02827.x · DOI · Paper page
  23. 10.1086/507643 · DOI
  24. 10.1016/S0891-5520(05)70152-5 · DOI
  25. 10.1542/peds.110.2.285 · DOI · Paper page
  26. 10.1038/sj.jp.7211496 · DOI
  27. 10.1128/CMR.17.3.638-680.2004 · DOI · Paper page
  28. 10.2165/00019053-200725090-00004 · DOI
  29. 10.1086/502522 · DOI · Paper page
  30. 10.1128/CMR.17.1.218-234.2004 · DOI · Paper page
  31. 10.1056/NEJM199011153232004 · DOI · Paper page
  32. Swingler G, 2007, Conjugate vaccines for preventing Haemophilus influenzae type b infections, Cochrane Database of Systematic Reviews, 2, CD001729
  33. 10.1056/NEJMcp063561 · DOI · Paper page
  34. 10.1542/peds.101.4.604 · DOI · Paper page
  35. 10.1097/00006454-200209000-00005 · DOI · Paper page
  36. Fattom A, 1990, Synthesis and immuno‐logic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A, Infect Immun, 58, 2367, 10.1128/iai.58.7.2367-2374.1990 · DOI
  37. 10.1128/IAI.61.3.1023-1032.1993 · DOI
  38. 10.1128/iai.64.5.1659-1665.1996 · DOI · Paper page
  39. 10.1128/IAI.65.10.4146-4151.1997 · doi:10.1128/iai.65.10.4146-4151.1997
  40. 10.1056/NEJMoa011297 · DOI · Paper page
  41. Karakawa WW, 1988, Capsular antibodies induce type‐specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes, Infect Immun, 56, 1090, 10.1128/iai.56.5.1090-1095.1988 · doi:10.1128/iai.56.5.1090-1095.1988
  42. 10.1099/00222615-41-4-259 · DOI
  43. 10.1111/j.1365-2958.2005.04978.x · DOI
  44. 10.1128/IAI.68.9.4865-4871.2000 · DOI
  45. AhmadA DaviesJA RavenhillKL SkinnerGRB.Development of a vaccine against staphylococcal infections. In 12th International Symposium on Staphylococci and Staphylococcal Infections Maastricht The Netherlands 2006 Abstract p‐091.
  46. 10.1016/S0966-842X(98)01400-0 · DOI · Paper page
  47. 10.1016/S0065-2911(06)51004-5 · DOI · Paper page
  48. 10.1111/j.1365-2958.1994.tb00304.x · DOI · Paper page
  49. Vaudaux PE, 1995, Use of adhesion‐defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts, Infect Immun, 63, 585, 10.1128/iai.63.2.585-590.1995 · DOI · Paper page
  50. 10.1128/IAI.63.12.4738-4743.1995 · DOI · Paper page
  51. 10.1111/j.1365-2958.1995.tb02316.x · DOI · Paper page
  52. 10.1128/IAI.64.12.4915-4921.1996 · DOI · Paper page
  53. 10.1086/324430 · DOI · Paper page
  54. 10.1128/AAC.47.11.3400-3406.2003 · DOI
  55. 10.1128/AAC.50.2.511-518.2006 · DOI
  56. 10.1097/01.inf.0000180504.66437.1f · DOI
  57. 10.1016/j.jpeds.2007.04.060 · DOI
  58. 10.1053/siny.2002.0116 · doi:10.1053/siny.2002.0116
  59. Carr R, 2003, G‐CSF and GM‐CSF for treating or preventing neonatal infections, Cochrane Database of Systematic Reviews, 3, CD003066
  60. 10.1128/IAI.71.12.6864-6870.2003 · DOI
  61. 10.1016/j.vaccine.2004.08.015 · DOI
  62. 10.1128/AAC.00096-06 · DOI
  63. 10.1128/AAC.00407-06 · DOI
  64. 10.1128/AAC.00570-07 · DOI
  65. 10.1128/IAI.72.12.6757-6763.2004 · DOI · Paper page
  66. 10.1128/IAI.68.6.3200-3209.2000 · DOI
  67. 10.1007/BF00276534 · DOI
  68. 10.1078/0171-2985-00285 · DOI
  69. 10.1084/jem.193.3.393 · DOI · Paper page
  70. 10.1084/jem.20020322 · DOI · Paper page
  71. WeismanLE ThackrayHM Garcia‐PratsJAet al.A phase 1/2 double blind placebo‐controlled dose escalation safety and pharmo kinetic study in very low birth weight neonates of pagibaximab (BSYX‐ALLO) an anti‐staphylococcal monodonal antibody for the prevention of staphylococcal bloodstream infections. Antimicrob Agents Chemother 2009 Apr 20 (Epub ahead of print). · DOI
  72. 10.1128/IAI.70.8.4433-4440.2002 · DOI · Paper page
  73. 10.1128/IAI.67.10.5427-5433.1999 · DOI · Paper page
  74. 10.1128/IAI.00078-07 · DOI
  75. 10.1111/j.1365-2958.1996.tb02548.x · DOI · Paper page
  76. 10.1074/jbc.M411374200 · DOI · Paper page
  77. 10.1086/497604 · DOI
  78. 10.1128/IAI.73.10.6752-6762.2005 · DOI · Paper page
  79. 10.1016/j.vaccine.2006.03.020 · DOI
  80. 10.1016/j.imlet.2004.07.007 · DOI
  81. Mohamed N, 2005, Heteropolymers: a novel technology against blood‐borne infections, Curr Opin Mol Ther, 7, 144
  82. 10.1034/j.1600-065x.2001.1830102.x · DOI
  83. Palma M, 1996, Lack of the extracellular 19‐kilodalton fibrinogen‐binding protein from Staphylococcus aureus decreases virulence in experimental wound infection, Infect Immun, 64, 5284, 10.1128/iai.64.12.5284-5289.1996 · DOI
  84. 10.1111/j.1365-3083.2006.01735.x · DOI
  85. 10.1126/science.274.5294.1859 · DOI · Paper page
  86. 10.1111/j.1462-5822.2006.00740.x · DOI
  87. Adlam C, 1977, Effect of immunization with highly purified alpha‐ and beta‐toxins on staphylococcal mastitis in rabbits, Infect Immun, 17, 250, 10.1128/iai.17.2.250-256.1977 · DOI
  88. 10.1128/IAI.68.10.6052-6055.2000 · DOI
  89. 10.1128/IAI.64.5.1839-1841.1996 · DOI
  90. 10.1084/jem.20072208 · DOI · Paper page
  91. 10.1128/CMR.13.1.16 · DOI · Paper page
  92. 10.1111/j.1444-0903.2005.00984.x · doi:10.1111/j.1444-0903.2005.00984.x
  93. Lowell GH, 1996, Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome‐toxoid vaccines, Infect Immun, 64, 4686, 10.1128/iai.64.11.4686-4693.1996 · doi:10.1128/iai.64.11.4686-4693.1996
  94. 10.1128/IAI.70.5.2278-2281.2002 · doi:10.1128/iai.70.5.2278-2281.2002
  95. 10.1016/S0264-410X(01)00470-4 · doi:10.1016/s0264-410x(01)00470-4
  96. 10.1016/j.femsim.2005.01.010 · DOI
  97. 10.1128/IAI.73.1.174-180.2005 · doi:10.1128/iai.73.1.174-180.2005
  98. 10.1086/315023 · DOI
  99. 10.1086/377308 · DOI
  100. 10.1016/j.micinf.2006.09.001 · doi:10.1016/j.micinf.2006.09.001
  101. 10.1002/cbic.200700023 · DOI
  102. 10.1016/j.ijmm.2004.06.013 · DOI
  103. 10.1016/j.chembiol.2007.08.013 · DOI · Paper page
  104. 10.4049/jimmunol.175.2.633 · DOI · Paper page
  105. 10.7326/0003-4819-138-7-200304010-00011 · DOI
  106. 10.1016/S0264-410X(02)00100-7 · DOI
  107. 10.1016/j.vaccine.2007.04.067 · DOI
  108. 10.1016/j.vaccine.2006.09.043 · DOI
  109. 10.1093/jac/44.6.767 · doi:10.1093/jac/44.6.767
  110. 10.1016/S0264-410X(02)00738-7 · doi:10.1016/s0264-410x(02)00738-7
  111. Roth DM, 2006, Evaluation of the humoral immune response in Balb/C mice immunized with a naked DNA vaccine anti‐methicillin‐resistant Staphylococcus aureus, Genet Mol Res, 5, 503
  112. 10.1056/NEJM200101043440102 · DOI · Paper page
  113. 10.1007/s15010-005-4012-9 · DOI · Paper page
  114. 10.1086/520663 · DOI
  115. 10.1128/IAI.74.4.2145-2153.2006 · DOI · Paper page
  116. 10.1038/nm991 · DOI · Paper page
  117. 10.1016/j.carres.2006.01.012 · DOI
  118. 10.1086/429692 · DOI · Paper page
  119. 10.1093/infdis/167.2.365 · DOI
  120. 10.1093/infdis/171.1.93 · DOI · Paper page
  121. 10.1097/01.inf.0000143645.58215.f0 · doi:10.1097/01.inf.0000143645.58215.f0
  122. 10.1086/423379 · DOI · Paper page
  123. 10.1078/1438-4221-00241 · DOI · Paper page
  124. 10.1086/509807 · DOI
  125. 10.1128/IAI.69.4.2031-2036.2001 · DOI
  126. 10.1016/j.vaccine.2006.02.055 · DOI
  127. Welch PG, 1996, Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide– Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis, J Am Soc Nephrol, 7, 247, 10.1681/ASN.V72247 · DOI
  128. 10.1016/j.amjmed.2005.07.011 · DOI
  129. 10.1002/jmv.20936 · doi:10.1002/jmv.20936
  130. 10.2165/00003088-199222060-00003 · doi:10.2165/00003088-199222060-00003
  131. 10.1128/IAI.73.6.3502-3511.2005 · doi:10.1128/iai.73.6.3502-3511.2005
  132. 10.1086/520932 · DOI

Cited by

See all 1

Metadata

Authors
Schaffer, A. C., & Lee, J. C.
Venue
Staphylococci in Human Disease
Publisher
Wiley
Published
2009-10-02
Pages
594-611
DOI
10.1002/9781444308464.ch32
Cited by
1
References
11
Language
en
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vaccine‐Based Strategies for Prevention of Staphylococcus Aureus Infection. https://app.cochat.ai/papers/10.1002/9781444308464.ch32
The paper
Schaffer, A. C., & Lee, J. C. (2009). Vaccine‐Based Strategies for Prevention of Staphylococcus Aureus Infection. Staphylococci in Human Disease. https://doi.org/10.1002/9781444308464.ch32

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.